DK140834C - - Google Patents

Info

Publication number
DK140834C
DK140834C DK457475A DK457475A DK140834C DK 140834 C DK140834 C DK 140834C DK 457475 A DK457475 A DK 457475A DK 457475 A DK457475 A DK 457475A DK 140834 C DK140834 C DK 140834C
Authority
DK
Denmark
Application number
DK457475A
Other languages
Danish (da)
Other versions
DK140834B (da
DK457475A (cg-RX-API-DMAC7.html
Inventor
U Fischer
E Lorch
Original Assignee
Hoffmann F. La Roche & Co Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann F. La Roche & Co Ag filed Critical Hoffmann F. La Roche & Co Ag
Publication of DK457475A publication Critical patent/DK457475A/da
Publication of DK140834B publication Critical patent/DK140834B/da
Application granted granted Critical
Publication of DK140834C publication Critical patent/DK140834C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24Y being a hetero atom
    • C07C279/26X and Y being nitrogen atoms, i.e. biguanides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK457475AA 1974-10-11 1975-10-10 Analogifremgangsmåde til fremstilling af biguanidsalte. DK140834B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1369774A CH602612A5 (cg-RX-API-DMAC7.html) 1974-10-11 1974-10-11

Publications (3)

Publication Number Publication Date
DK457475A DK457475A (cg-RX-API-DMAC7.html) 1976-04-12
DK140834B DK140834B (da) 1979-11-26
DK140834C true DK140834C (cg-RX-API-DMAC7.html) 1980-04-28

Family

ID=4394567

Family Applications (1)

Application Number Title Priority Date Filing Date
DK457475AA DK140834B (da) 1974-10-11 1975-10-10 Analogifremgangsmåde til fremstilling af biguanidsalte.

Country Status (26)

Country Link
US (1) US4028402A (cg-RX-API-DMAC7.html)
JP (1) JPS51125718A (cg-RX-API-DMAC7.html)
AR (1) AR209457A1 (cg-RX-API-DMAC7.html)
AT (1) AT343676B (cg-RX-API-DMAC7.html)
BE (1) BE834369A (cg-RX-API-DMAC7.html)
BR (1) BR7506595A (cg-RX-API-DMAC7.html)
CA (1) CA1053258A (cg-RX-API-DMAC7.html)
CH (1) CH602612A5 (cg-RX-API-DMAC7.html)
CU (1) CU34371A (cg-RX-API-DMAC7.html)
DD (1) DD123322A5 (cg-RX-API-DMAC7.html)
DE (1) DE2542598A1 (cg-RX-API-DMAC7.html)
DK (1) DK140834B (cg-RX-API-DMAC7.html)
ES (1) ES441673A1 (cg-RX-API-DMAC7.html)
FI (1) FI752626A7 (cg-RX-API-DMAC7.html)
FR (1) FR2287221A1 (cg-RX-API-DMAC7.html)
GB (1) GB1473256A (cg-RX-API-DMAC7.html)
IE (1) IE41807B1 (cg-RX-API-DMAC7.html)
IL (1) IL48116A (cg-RX-API-DMAC7.html)
LU (1) LU73557A1 (cg-RX-API-DMAC7.html)
NL (1) NL7511890A (cg-RX-API-DMAC7.html)
NO (1) NO753447L (cg-RX-API-DMAC7.html)
PH (1) PH12279A (cg-RX-API-DMAC7.html)
PL (1) PL95259B1 (cg-RX-API-DMAC7.html)
SE (1) SE7511357L (cg-RX-API-DMAC7.html)
SU (1) SU572200A3 (cg-RX-API-DMAC7.html)
ZA (1) ZA755861B (cg-RX-API-DMAC7.html)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2401898A1 (fr) * 1977-09-05 1979-03-30 Aec Chim Organ Biolog Nouveau sel de l'acide patoique
DE19616486C5 (de) 1996-04-25 2016-06-30 Royalty Pharma Collection Trust Verfahren zur Senkung des Blutglukosespiegels in Säugern
US20020006899A1 (en) * 1998-10-06 2002-01-17 Pospisilik Andrew J. Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
EP1004304A4 (en) 1996-12-24 2002-10-16 Sumitomo Pharma COMPOSITION CONTAINING ASCORBIC ACID
DE19823831A1 (de) 1998-05-28 1999-12-02 Probiodrug Ges Fuer Arzneim Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
DE19828114A1 (de) 1998-06-24 2000-01-27 Probiodrug Ges Fuer Arzneim Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
DE19828113A1 (de) 1998-06-24 2000-01-05 Probiodrug Ges Fuer Arzneim Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
DE19834591A1 (de) 1998-07-31 2000-02-03 Probiodrug Ges Fuer Arzneim Verfahren zur Steigerung des Blutglukosespiegels in Säugern
US20030176357A1 (en) * 1998-10-06 2003-09-18 Pospisilik Andrew J. Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
DE19926233C1 (de) 1999-06-10 2000-10-19 Probiodrug Ges Fuer Arzneim Verfahren zur Herstellung von Thiazolidin
DE19940130A1 (de) * 1999-08-24 2001-03-01 Probiodrug Ges Fuer Arzneim Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung
AU780855B2 (en) * 1999-10-06 2005-04-21 Kurokawa, Kiyoshi Carbonyl stress-decreasing agent
US20080076811A1 (en) * 2000-01-21 2008-03-27 Bork Balkan Combinations comprising depeptidypeptidase-iv inhibitors and antidiabetic agents
EP2055302B1 (en) * 2000-03-31 2014-09-10 Royalty Pharma Collection Trust Method for the improvement of islet signaling in diabetes mellitus and for its prevention
FR2809310B1 (fr) 2000-05-26 2004-02-13 Centre Nat Rech Scient Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant
JP2005097117A (ja) * 2000-06-30 2005-04-14 Chugai Pharmaceut Co Ltd 糖尿病治療剤
KR20030096227A (ko) * 2000-10-27 2003-12-24 프로비오드룩 아게 신경 및 신경정신 질환의 치료방법
US7132104B1 (en) 2000-10-27 2006-11-07 Probiodrug Ag Modulation of central nervous system (CNS) dipeptidyl peptidase IV (DPIV) -like activity for the treatment of neurological and neuropsychological disorders
US6890905B2 (en) 2001-04-02 2005-05-10 Prosidion Limited Methods for improving islet signaling in diabetes mellitus and for its prevention
US20030130199A1 (en) 2001-06-27 2003-07-10 Von Hoersten Stephan Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
US7368421B2 (en) 2001-06-27 2008-05-06 Probiodrug Ag Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis
DE10150203A1 (de) 2001-10-12 2003-04-17 Probiodrug Ag Peptidylketone als Inhibitoren der DPIV
WO2003015768A2 (en) * 2001-08-16 2003-02-27 Probiodrug Ag Use of inhibitors of proline endopeptidase to modulate inositol (1,4,5) triphosphate concentration dependent on intracellular signal cascades
US6844316B2 (en) 2001-09-06 2005-01-18 Probiodrug Ag Inhibitors of dipeptidyl peptidase I
DK1480961T3 (da) 2002-02-28 2007-05-07 Prosidion Ltd Glutaminylbaserede DPIV-inhibitorer
US20030232761A1 (en) * 2002-03-28 2003-12-18 Hinke Simon A. Novel analogues of glucose-dependent insulinotropic polypeptide
US20040033051A1 (en) * 2002-08-16 2004-02-19 Ip Kiril Kun Wan Method and system for producing and displaying visual presentations which inhibit off-screen duplication
WO2004031374A2 (en) * 2002-09-18 2004-04-15 Prosidion Ltd. Secondary binding site of dipeptidyl peptidase iv (dp iv)
US20040058876A1 (en) * 2002-09-18 2004-03-25 Torsten Hoffmann Secondary binding site of dipeptidyl peptidase IV (DP IV)
DK2206496T3 (da) 2003-05-05 2014-12-15 Probiodrug Ag Screening af inhibitorer af pyroglutaminsyredannelse i amyloid beta-peptid
ZA200508439B (en) 2003-05-05 2007-03-28 Probiodrug Ag Medical use of inhibitors of glutaminyl and glutamate cyclases
DK1675578T3 (da) * 2003-10-15 2013-08-26 Probiodrug Ag Inhibitorer af glutaminyl- og glutamatcyclaser til behandling af de neurodegenerative sygdomme FBD og FDD
US20100099721A1 (en) * 2003-11-03 2010-04-22 Probiodrug Ag Novel compounds for the treatment of neurological disorders
US20050171112A1 (en) * 2003-11-03 2005-08-04 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
EP1713780B1 (en) 2004-02-05 2012-01-18 Probiodrug AG Novel inhibitors of glutaminyl cyclase
US8058312B2 (en) * 2007-01-29 2011-11-15 Hanall Biopharma Co., Ltd. N, N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
WO2008097861A2 (en) * 2007-02-02 2008-08-14 Braincells, Inc. MODULATION OF NEUROGENESIS WITH BIGUANIDES AND GSK3-ß AGENTS
JP5292404B2 (ja) * 2007-09-21 2013-09-18 ハンオル バイオファーマ カンパニー,リミテッド N,n−ジメチルイミドジカルボンイミド酸ジアミドのジカルボン酸塩、その製造方法、及びその薬剤学的組成物
WO2009088220A2 (ko) * 2008-01-08 2009-07-16 Hanall Pharmaceutical Company. Ltd N,n-디메틸 이미도디카르본이미딕 디아미드의 니코틴산염, 그의 제조방법 및 그를 포함하는 약제학적 조성물
MX2011000135A (es) * 2008-06-26 2011-02-25 Silanes Sa De Cv Lab Una nueva sal de glicinato de metformina para el control de la glucosa en sangre.
WO2010146604A2 (en) 2009-06-18 2010-12-23 Exemed Pharmaceuticals Processes for preparing metformin hydrochloride
WO2011049400A2 (ko) * 2009-10-23 2011-04-28 한올바이오파마주식회사 N,n-디메틸 이미도디카르본이미딕 디아미드의 산 부가염을 포함하는 항암용 약제학적 조성물
KR101324283B1 (ko) 2010-04-27 2013-11-01 한올바이오파마주식회사 바이구아나이드 화합물의 신규 염, 그의 제조방법, 그를 포함하는 약제학적 조성물
WO2018060962A2 (en) 2016-09-30 2018-04-05 Laboratorios Silanes S.A. De C.V. Metformin amino acid compounds and methods of using the same
WO2018060959A1 (en) 2016-09-30 2018-04-05 Laboratorios Silanes S.A. De C.V. Metformin glycinate, pharmaceutical compositions comprising the same, and methods of using the same
CN106986791A (zh) * 2017-05-11 2017-07-28 杜剑平 一种治疗肿瘤的药物化合物及其制备方法和应用
CN107118130A (zh) * 2017-05-11 2017-09-01 杜剑平 一类治疗肿瘤的药物化合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3179562A (en) * 1961-08-23 1965-04-20 Du Pont Treatment of diabetes with alpha, alpha substituted acetic acid derivatives

Also Published As

Publication number Publication date
ATA776375A (de) 1977-10-15
AU8497775A (en) 1977-03-24
DK140834B (da) 1979-11-26
ZA755861B (en) 1976-08-25
DK457475A (cg-RX-API-DMAC7.html) 1976-04-12
IE41807B1 (en) 1980-03-26
US4028402A (en) 1977-06-07
NL7511890A (nl) 1976-04-13
PL95259B1 (pl) 1977-10-31
CA1053258A (en) 1979-04-24
LU73557A1 (cg-RX-API-DMAC7.html) 1977-05-24
SE7511357L (sv) 1976-04-12
AT343676B (de) 1978-06-12
IL48116A0 (en) 1975-11-25
CU34371A (es) 1979-06-01
JPS51125718A (en) 1976-11-02
BE834369A (fr) 1976-04-12
ES441673A1 (es) 1977-04-01
DD123322A5 (cg-RX-API-DMAC7.html) 1976-12-12
IL48116A (en) 1979-07-25
NO753447L (cg-RX-API-DMAC7.html) 1976-04-13
SU572200A3 (ru) 1977-09-05
FR2287221A1 (fr) 1976-05-07
FI752626A7 (cg-RX-API-DMAC7.html) 1976-04-12
CH602612A5 (cg-RX-API-DMAC7.html) 1978-07-31
GB1473256A (en) 1977-05-11
DE2542598A1 (de) 1976-04-22
PH12279A (en) 1978-12-12
AR209457A1 (es) 1977-04-29
BR7506595A (pt) 1976-08-17
IE41807L (en) 1976-04-11

Similar Documents

Publication Publication Date Title
AU495841B2 (cg-RX-API-DMAC7.html)
AU7459374A (cg-RX-API-DMAC7.html)
AU474179B2 (cg-RX-API-DMAC7.html)
AU495898B2 (cg-RX-API-DMAC7.html)
AU7474374A (cg-RX-API-DMAC7.html)
AU7465674A (cg-RX-API-DMAC7.html)
AU480764A (cg-RX-API-DMAC7.html)
BE829576A (cg-RX-API-DMAC7.html)
AU480308A (cg-RX-API-DMAC7.html)
BG19872A1 (cg-RX-API-DMAC7.html)
AU480578A (cg-RX-API-DMAC7.html)
AU480758A (cg-RX-API-DMAC7.html)
BG19759A1 (cg-RX-API-DMAC7.html)
AU480977A (cg-RX-API-DMAC7.html)
AU480994A (cg-RX-API-DMAC7.html)
AU481898A (cg-RX-API-DMAC7.html)
AU482014A (cg-RX-API-DMAC7.html)
AU482149A (cg-RX-API-DMAC7.html)
AU482236A (cg-RX-API-DMAC7.html)
AU482272A (cg-RX-API-DMAC7.html)
AU482307A (cg-RX-API-DMAC7.html)
AU480227A (cg-RX-API-DMAC7.html)
AU480170A (cg-RX-API-DMAC7.html)
AU480070A (cg-RX-API-DMAC7.html)
AU479986A (cg-RX-API-DMAC7.html)